Association of HLA-C3 and smoking with vasculitis in patients with rheumatoid arthritis

Arthritis and Rheumatism

Volumn 54, Issue 9, 2006, Pages 2776-2783

  Turesson, Carl ^a,b   Schaid, Daniel J ^b   Weyand, Cornelia M ^c   Jacobsson, Lennart T ^a   Goronzy, Jörg J ^c   Petersson, Ingemar F ^d   Dechant, Sonja A ^b   Nyähll Wåhlin, Britt Marie ^d   Truedsson, Lennart ^a   Sturfelt, Gunnar ^a   Matteson, Eric L ^b  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

^b Mayo Clinic   (United States)

^c EMORY UNIVERSITY   (United States)

^d Spenshult Hospital for Rheumatic Diseases   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINUCLEAR ANTIBODY; HLA C ANTIGEN; HLA C3 ANTIGEN; HLA C7 ANTIGEN; HLA DR ANTIGEN; UNCLASSIFIED DRUG;

ADULT; ALLELE; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DATA BASE; DISEASE ASSOCIATION; ENVIRONMENTAL FACTOR; EXTRAARTICULAR MANIFESTATIONS OF RHEUMATOID ARTHRITIS; FEMALE; GENE FREQUENCY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; PATHOGENESIS; POLYMERASE CHAIN REACTION; PREDICTOR VARIABLE; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SEQUENCE ANALYSIS; SMOKING; VASCULITIS;

ADULT; ARTHRITIS, RHEUMATOID; FEMALE; GENOTYPE; HISTOCOMPATIBILITY TESTING; HLA-C ANTIGENS; HUMANS; MALE; MIDDLE AGED; SMOKING; VASCULITIS;

EID: 33749344148     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/art.22057     Document Type: Article

References (47)

1. Del Rincon ID, Williams K, Stern MP, Freeman GL, Escalante A. High incidence of cardiovascular events in a rheumatoid arthritis cohort not explained by traditional cardiac risk factors. Arthritis Rheum 2001;44:2737-45.
2. Solomon DH, Karlson EW, Rimm EB, Cannuscio CC, Mandl LA, Manson JE, et al. Cardiovascular morbidity and mortality in women diagnosed with rheumatoid arthritis. Circulation 2003;107:1303-7.
3. Turesson C, Jarenros A, Jacobsson L. Increased incidence of cardiovascular disease in patients with rheumatoid arthritis: results from a community based study. Ann Rheum Dis 2004;63:952-5.
4. Jacobsson LT, Knowler WC, Pillemer S, Hanson RL, Pettitt DJ, Nelson RG, et al. Rheumatoid arthritis and mortality: a longitudinal study in Pima Indians. Arthritis Rheum 1993;36:1045-53.
5. Turesson C, O'Fallon WM, Crowson CS, Gabriel SE, Matteson EL. Occurrence of extraarticular disease manifestations is associated with excess mortality in a community based cohort of patients with rheumatoid arthritis. J Rheumatol 2002;29:62-7.
6. Gabriel SE, Crowson CS, Kremers HM, Doran MF, Turesson C, O'Fallon WM, et al. Survival in rheumatoid arthritis: a population-based analysis of trends over 40 years. Arthritis Rheum 2003;48:54-8.
7. Weyand CM, McCarthy TG, Goronzy JJ. Correlation between disease phenotype and genetic heterogeneity in rheumatoid arthritis. J Clin Invest 1995;95:2120-6.
8. Goronzy JJ, Matteson EL, Fulbright JW, Warrington KJ, Chang-Miller A, Hunder GG, et al. Prognostic markers of radiographic progression in early rheumatoid arthritis. Arthritis Rheum 2004;50:43-54.
9. Gorman JD, Lum RF, Chen JJ, Suarez-Almazor ME, Thomson G, Criswell LA. Impact of shared epitope genotype and ethnicity on erosive disease: a meta-analysis of 3,240 rheumatoid arthritis patients. Arthritis Rheum 2004;50:400-12.
10. Weyand CM, Xie C, Goronzy JJ. Homozygosity for the HLA-DRB1 allele selects for extraarticular manifestations in rheumatoid arthritis. J Clin Invest 1992;89:2033-9.
11. Weyand CM, Goronzy JJ. Functional domains on HLA-DR molecules: implications for the linkage of HLA-DR genes to different autoimmune diseases. Clin Immunol Immunopathol 1994;70:91-8.
12. Turesson C, Weyand CM, Matteson EL. Genetics of rheumatoid arthritis: is there a pattern predicting extraarticular manifestations? Arthritis Rheum 2004;51:853-63.
13. Martens PB, Goronzy JJ, Schaid D, Weyand CM. Expansion of unusual CD4+ T cells in severe rheumatoid arthritis. Arthritis Rheum 1997;40:1106-14.
14. Goronzy JJ, Weyand CM. Aging, autoimmunity and arthritis. T-cell senescence and contraction of T-cell repertoire diversity: catalysts of autoimmunity and chronic inflammation. Arthritis Res Ther 2003;5:225-34.
15. Yen JH, Moore BE, Nakajima T, Scholl D, Schaid DJ, Weyand CM, et al. Major histocompatibility complex class I-recognizing receptors are disease risk genes in rheumatoid arthritis. J Exp Med 2001;193:1159-67.
16. Williams RC, Jacobsson LT, Knowler WC, del Puente A, Kostyu D, McAuley JE, et al. Meta-analysis reveals association between most common class II haplotype in full-heritage Native Americans and rheumatoid arthritis. Hum Immunol 1995;42:90-4.
17. Matteson EL, Weyand CM, Fulbright JW, Chrislianson TJ, McClelland RL, Goronzy JJ. How aggressive should initial therapy for rheumatoid arthritis be? Factors associated with response Io "non-aggressive" DMARD treatment and perspective from a 2-yr open label trial. Rheumatology (Oxford) 2004;43:619-25.
18. Silman AJ, Newman J, MacGregor AJ. Cigarette smoking increases the risk of rheumatoid arthritis: results from a nationwide study of disease-discordant twins. Arthritis Rheum 1996;39:732-5.
19. Wolfe F. The effect of smoking on clinical, laboratory, and radiographic status in rheumatoid arthritis. J Rheumatol 2000;27:630-7.
20. Masdottir B, Jonsson T, Manfredsdottir V, Vikingsson A, Brekkan A, Valdimarsson H. Smoking, rheumatoid factor isotypes and severity of rheumatoid arthritis. Rheumatology (Oxford) 2000;39:1202-5.
21. Harrison BJ, Silman AJ, Wiles NJ, Scoll DG, Symmons DP. The association of cigarette smoking with disease outcome in patients with early inflammatory polyarthritis. Arthritis Rheum 2001;44:323-30.
22. Struthers GR, Scott DL, Delamere JP, Sheppeard H, Kitt M. Smoking and rheumatoid vasculitis. Rheumatol Int 1981;1:145-6.
23. Turesson C, O'Fallon WM, Crowson CS, Gabriel SE, Matteson EL. Extra-articular disease manifestations in rheumatoid arthritis: incidence trends and risk factors over 46 years. Ann Rheum Dis 2003;62:722-7.
24. Turesson C, Jacobsson L, Bergstrom U. Extra-articular rheumatoid arthritis: prevalence and mortality. Rheumatology (Oxford) 1999;38:668-74.
25. Turesson C, Jacobsson LT. Epidemiology of extra-articular manifestations in rheumatoid arthritis. Scand J Rheumatol 2004;33:65-72.
26. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-24.
27. Jacobsson L, Lindroth Y, Marsal L, Tejler L. The Malmo model for private and public rheumatological outpatient care: cooperation makes it possible to introduce disease modifying treatment quickly. Lakartidningen 2001;98:4710-6. In Swedish.
28. Turesson C, Jacobsson L, Ryden Ahlgren A, Sturfelt G, Wollmer P, Lanne T. Increased stiffness of the abdominal aorta in women with rheumatoid arthritis. Rheumatology (Oxford) 2005;44:896-901.
29. Turesson C, Jacobsson L, Bergstrom U, Truedsson L, Sturfelt G. Predictors of extra-articular manifestations in rheumatoid arthritis. Scand J Rheumatol 2000;29:358-64.
30. Svensson B, Schaufelberger C, Teleman A, Theander J, for the BARFOT Study Group. Remission and response to early treatment of RA assessed by the Disease Activity Score. Rheumatology (Oxford) 2000;39:1031-6.
31. Sasieni PD. From genotypes to genes: doubling the sample size. Biometrics 1997;53:1253-61.
32. Devlin B, Roeder K. Genomic control for association studies. Biometrics 1999;55:997-1004.
33. Weir B. Genetic data analysis II. Sunderland (MA): Sinauer Associates, Inc.; 1996.
34. Turesson C, Schaid DJ, Weyand CM, Jacobsson LT, Goronzy JJ, Petersson IF, et al. The impact of HLA-DRB1 genes on extraarticular disease manifestations in rheumatoid arthritis. Arthritis Res Ther 2005;7:1386-93.
35. Puechal X, Said G, Hilliquin P, Coste J, Job-Deslandre C, Lacroix C, et al. Peripheral neuropathy with necrotizing vasculitis in rheumatoid arthritis: a clinicopathologic and prognostic study of thirty-two patients. Arthritis Rheum 1995;38:1618-29.
36. Vilches C, Parham P. KIR: diverse, rapidly evolving receptors of innate and adaptive immunity. Annu Rev Immunol 2002;20:217-51.
37. Liuzzo G, Goronzy JJ, Yang H, Kopecky SL, Holmes DR, Frye RL, et al. Monoclonal T-cell proliferation and plaque instability in acute coronary syndromes. Circulation 2000;101:2883-8.
38. Warrington KJ, Takemura S, Goronzy JJ, Weyand CM. CD4+CD28- T cells in rheumatoid arthritis patients combine features of the innate and adaptive immune systems. Arthritis Rheum 2001;44:13-20.
39. Snyder MR, Nakajima T, Leibson PJ, Weyand CM, Goronzy JJ. Stimulatory killer Ig-like receptors modulate T cell activation through DAP12-dependent and DAP12-independent mechanisms. J Immunol 2004;173:3725-31.
40. Saulquin X, Gastinel LN, Vivier E. Crystal structure of the human natural killer cell activating receptor KIR2DS2 (CD158j). J Exp Med 2003;197:933-8.
41. Padyukov L, Silva C, Stolt P, Alfredsson L, Klareskog L. A gene-environment interaction between smoking and shared epitope genes in HLA-DR provides a high risk of seropositive rheumatoid arthritis. Arthritis Rheum 2004;50:3085-92.
42. Wilhelmsen L, Wedel H, Tibblin G. Multivariate analysis of risk factors for coronary heart disease. Circulation 1973;48:950-8.
43. Voskuyl AE, Zwinderman AH, Westedt ML, Vandenbroucke JP, Breedveld FC, Hazes JM. Factors associated with the development of vasculitis in rheumatoid arthritis: results of a case-control study. Ann Rheum Dis 1996;55:190-2.
44. Scott DG, Bacon PA, Allen C, Elson CJ, Wallington T. IgG rheumatoid factor, complement and immune complexes in rheumatoid synovitis and vasculitis: comparative and serial studies during cytotoxic therapy. Clin Exp Immunol 1981;43:54-63.
45. Melsom RD, Horsfall AC, Schrieber L, Charles P, Maini RN. Anti-Clq affinity isolated circulating immune complexes correlate with extra-articular rheumatoid disease. Rheumatol Int 1986;6:227-31.
46. Edwards JC, Szczepanski L, Szechinski J, Filipowicz-Sosnowska A, Emery P, Close DR, et al. Efficacy of B-cell-targeted therapy with rituximab in patients with rheumatoid arthritis. N Engl J Med 2004;350:2572-81.
47. Kremer JM, Westhovens R, Leon M, Di Giorgio E, Alten R, Steinfeld S, et al. Treatment of rheumatoid arthritis by selective inhibition of T-cell activation with fusion protein CTLA4Ig. N Engl J Med 2003;349:1907-15.